Skip to main content
Top
Published in: Rheumatology International 9/2006

01-07-2006 | Preliminary results

Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever

Authors: Eren Erken, Huseyin T. E. Ozer, Ramazan Gunesacar

Published in: Rheumatology International | Issue 9/2006

Login to get access

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by recurrent attacks of fever, polyserositis and arthritis. A vast array of cytokines were analysed in these patients, however, little is known about the pro-inflammatory cytokine interleukin (IL)-12. Plasma IL-12 and IL-10 were measured in 24 patients with FMF (19 active, 5 inactive) and 18 healthy controls by ELISA. From 15 active patients blood was also drawn in attack-free period. Mean plasma IL-12 levels of the FMF patients (mean ± SEM, 6.84±3.59 pg/ml) were higher than the controls (0.13±0.09 pg/ml, P<0.001). Mean IL-12 levels of active (7.02±5.23 pg/ml) and inactive patients (6.89±5.61 pg/ml) were comparable, and they were higher compared to controls (P≤0.001). Mean plasma IL-10 levels of the total FMF patients (3.01±1.53 pg/ml) were also higher than the controls (P=0.024). Patients had higher IL-10 levels in attacks (3.83±2.02 pg/ml) compared to levels when they were in remission (1.86±1.59 pg/ml, P=0.046). Significantly elevated IL-12 levels in FMF patients regardless of activity may suggest the presence of a pro-inflammatory state also in the inactive period of FMF. Significant increase in IL-10 levels in FMF group may point to the compensatory suppression of inflammation in active periods of the disease.
Literature
1.
go back to reference Matzner Y, Partridge RE, Levy M, Babior BM (1984) Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 63:629–633PubMed Matzner Y, Partridge RE, Levy M, Babior BM (1984) Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 63:629–633PubMed
2.
go back to reference The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef
3.
go back to reference The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807CrossRef The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807CrossRef
4.
go back to reference Anton PA, Targan SR, Vigna SR, Durham M, Schwabe AD, Shanahan F (1988) Enhanced neutrophil chemiluminescence in familial Mediterranean fever. J Clin Immunol 8:148–156CrossRefPubMed Anton PA, Targan SR, Vigna SR, Durham M, Schwabe AD, Shanahan F (1988) Enhanced neutrophil chemiluminescence in familial Mediterranean fever. J Clin Immunol 8:148–156CrossRefPubMed
5.
go back to reference Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule-1 and interleukin-8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986PubMed Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule-1 and interleukin-8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986PubMed
6.
go back to reference Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A (2003) Th1 polarization in familial Mediterranean fever. J Rheumatol 30:2011–2013PubMed Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A (2003) Th1 polarization in familial Mediterranean fever. J Rheumatol 30:2011–2013PubMed
7.
go back to reference Oktem S, Yavuzsen TU, Sengul B, Akhunlar H, Akar S, Tunca M (2004) Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever patients and their first degree relatives. Clin Exp Rheumatol 22:S34–S36PubMed Oktem S, Yavuzsen TU, Sengul B, Akhunlar H, Akar S, Tunca M (2004) Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever patients and their first degree relatives. Clin Exp Rheumatol 22:S34–S36PubMed
8.
go back to reference Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337CrossRefPubMed Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337CrossRefPubMed
9.
go back to reference Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101CrossRefPubMed Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101CrossRefPubMed
10.
go back to reference Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JW, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890–897PubMed Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JW, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890–897PubMed
11.
go back to reference Erken E, Gunesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855PubMedCrossRef Erken E, Gunesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855PubMedCrossRef
12.
go back to reference Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I (2002) Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3:43–45CrossRefPubMed Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I (2002) Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3:43–45CrossRefPubMed
13.
go back to reference Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S (2004) Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 138:526–533CrossRefPubMed Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S (2004) Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 138:526–533CrossRefPubMed
14.
go back to reference Trinchieri G (1999) Interleukin 12. In: Theze J (ed) The cytokine network and immune functions. Oxford University Press, Oxford, pp 97–103 Trinchieri G (1999) Interleukin 12. In: Theze J (ed) The cytokine network and immune functions. Oxford University Press, Oxford, pp 97–103
15.
go back to reference Pretolani M, Stordeur P, Goldman M (1999) Interleukin 10. In: Theze J (ed) The cytokine network and immune functions. Oxford University Press, Oxford, pp 45–49 Pretolani M, Stordeur P, Goldman M (1999) Interleukin 10. In: Theze J (ed) The cytokine network and immune functions. Oxford University Press, Oxford, pp 45–49
16.
go back to reference Csiszar A, Nagy G, Gergely P, Pozsonyi T, Pocsik E (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464–470CrossRefPubMed Csiszar A, Nagy G, Gergely P, Pozsonyi T, Pocsik E (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464–470CrossRefPubMed
17.
go back to reference Liu TF, Jones BM (1998) Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE. Cytokine 10:148–153CrossRefPubMed Liu TF, Jones BM (1998) Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE. Cytokine 10:148–153CrossRefPubMed
18.
go back to reference Kim W, Min S, Cho M, Youn J, Min J, Lee S, Park S, Cho C, Kim H (2000) The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin Exp Immunol 119:175–181CrossRefPubMed Kim W, Min S, Cho M, Youn J, Min J, Lee S, Park S, Cho C, Kim H (2000) The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin Exp Immunol 119:175–181CrossRefPubMed
19.
go back to reference Turan B, Gallati H, Erdi H, Gurler A, Michel BA, Villiger PM (1997) Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet’s disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128–132PubMed Turan B, Gallati H, Erdi H, Gurler A, Michel BA, Villiger PM (1997) Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet’s disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128–132PubMed
20.
go back to reference Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet’s disease: a putative pathogenic role of IL-12. Arthritis Rheum 42:1967–1974CrossRefPubMed Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet’s disease: a putative pathogenic role of IL-12. Arthritis Rheum 42:1967–1974CrossRefPubMed
21.
go back to reference Keystone E, Wherry J, Grint P (1998) IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 24:629–639CrossRefPubMed Keystone E, Wherry J, Grint P (1998) IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 24:629–639CrossRefPubMed
Metadata
Title
Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever
Authors
Eren Erken
Huseyin T. E. Ozer
Ramazan Gunesacar
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0099-7

Other articles of this Issue 9/2006

Rheumatology International 9/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.